โ† All deals

CRYOPORT INC

Public Equity (NASDAQ)PublicLogisticsLife Sciences
๐Ÿ“ Brentwood, TN, United Statesโ€ข Founded 1999โ€ข 501-1000 employees
StreetZero Signal 61
Be the first to signal interest

About CRYOPORT INC

Cryoport, Inc. (Nasdaq: CYRX) is a leading global provider of integrated temperature-controlled supply chain solutions for the life sciences, with an emphasis on regenerative medicine and cell & gene therapies. The company supports biopharmaceutical firms, CDMOs, CROs, developers, and researchers with services and products to minimize risk across the cold chain. It operates from 50 strategic locations worldwide and offers bio-logistics, bio-storage, bio-processing, and cryogenic systems. Founded in 1999 and headquartered in Brentwood, TN, it is a public company with over 1,000 employees.

LATEST FUNDINGRule 144
$1.4M
Announced 2026-11-09
TOTAL RAISED$1.11B
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for CRYOPORT INC.

Free plan includes 3 full deal profiles every month.

EMPLOYEES501-1000
FOUNDED1999
HQBrentwood, TN, United States
Industry
Public Equity (NASDAQ)
Tags
PublicLogisticsLife SciencesSupply Chain

Investors

Key highlights

  • Public company (NASDAQ: CYRX) providing cold chain solutions for regenerative medicine.
  • Completed multiple post-IPO raises totaling over $1B including $350M debt in 2021.
  • Backed by Blackstone with 12 total funding rounds.
  • Operates 50 global locations serving biopharma and cell/gene therapy markets.
  • Reported 2026 revenue guidance of $197M-$199M.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account